☆ 4.7 Meeting Abstract

A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ovarian cancer (OVCA)

ANNALS OF ONCOLOGY (2016)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 27, Issue -, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdw435.29

Keywords

-

Categories

Oncology

Funding

  1. Pfizer

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.